Background Several routes of fecal microbiota transplantation (FMT) administration are
available for treating recurrent Clostridioides difficile infections (CDI), the most recent of …

Clostridioides difficile is an increasingly common pathogen both within and outside the
hospital and is responsible for a large clinical spectrum from asymptomatic carriage to …

Background Faecal microbiota transplantation is an emerging therapeutic option,
particularly for the treatment of recurrent Clostridioides difficile infection. Stool banks that …

Background: Faecal microbiota transplant (FMT) is a highly effective therapy for recurrent
Clostridioides difficile infection (rCDI) with cure rates ranging between 85 and 92%. The …

The human microbiome comprising microorganisms, their collective genomes and metabolic
products has gained tremendous research interest in oncology, as multiple cohorts and case …

Background Due to limited antibiotic options, carbapenem-resistant Enterobacteriaceae
(CRE) infections are associated with high non-relapse mortality after allogeneic …

Microbiota restoration therapy (MRT) compositions (eg, oral MRT compositions) and
methods for manufacturing MRT compositions are disclosed. An example method for …

目的应用Meta 分析评价冰冻粪菌移植(FMT) 治疗艰难梭菌感染(CDI) 相关腹泻的效果.
方法计算机检索CNKI, CBM, WanFang Data, PubMed, EMbase, Web of Science, The …

Objective: To evaluate the effect of frozen fecal microbiota transplantation (FMT) in the
treatment of Clostridium difficile infection-related diarrhea (CDI). Methods: CNKI, CBM …

Clostridioides difficile (C. difficile) is the leading cause of hospital acquired diarrhoeal
infection. The major risk factors associated with C. difficile infection (CDI) is age (65 and …